Strongyloidiasis
27 results
1 - 27
Strongyloidiasis 
No benefit to ivermectin for the treatment of COVID-19 in regions where strongyloidiasis is not endemic
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection- Introduction to intestinal helminthiasis
- Ivermectin is ineffective for patients with mild to moderate COVID-19
- Skin problems in returning travellers
- Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
- Prolonged abdominal complaints in travellers
- Prolonged diarrhoea in adults